Corheart 6 Left Ventricular Assist System

DEVICE5 trials

Sponsors

Shenzhen Core Medical Technology CO.,LTD., Nanjing First Hospital, Nanjing Medical University, China National Center for Cardiovascular Diseases

Conditions

End-stage Heart FailureHeart FailureRefractory Heart Failure

Unknown Phase

Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial

Active, not recruitingNCT05353816

Shenzhen Core Medical Technology CO.,LTD.End-stage Heart Failure

Start: 2022-01-26End: 2027-10-01Updated: 2026-02-02

Corheart 6 LVAS Study

RecruitingNCT05876000

Shenzhen Core Medical Technology CO.,LTD.Refractory Heart Failure

Start: 2024-05-14End: 2031-06-30Target: 53Updated: 2026-01-08

Corheart 6 LVAS LTFU

CompletedNCT05928273

Shenzhen Core Medical Technology CO.,LTD.End-stage Heart Failure

Start: 2021-12-20End: 2023-01-17Updated: 2023-07-03

Corheart 6 LVAS Long-term Follow-up Study

Not yet recruitingNCT06267612

Nanjing First Hospital, Nanjing Medical UniversityHeart Failure

Start: 2024-02-10End: 2030-06-30Target: 30Updated: 2024-02-20

Corheart 6: Long-term Cohort Study

RecruitingNCT07094919

China National Center for Cardiovascular DiseasesHeart Failure

Start: 2021-12-12End: 2030-09-30Target: 160Updated: 2025-07-31

Related Papers

A novel magnetically levitated intrapericardial left ventricular assist system in advanced heart failure-2-year results from a prospective, multi-centre study.

2026-01-09